Biologically targeted discovery-replication scan identifies G×G interaction in relation to risk of Barrett's esophagus and esophageal adenocarcinoma Journal Article


Authors: Yan, L.; He, Q.; Verma, S. P.; Zhang, X.; Giel, A. S.; Maj, C.; Graz, K.; Naderi, E.; Chen, J.; Ali, M. W.; Gharahkhani, P.; Shu, X.; Offit, K.; Shah, P. M.; Gerdes, H.; Molena, D.; Srivastava, A.; MacGregor, S.; BEACON Consortium; OCCAMS Consortium; Esophageal Cancer Consortium; Palles, C.; Thieme, R.; Vieth, M.; Gockel, I.; Vaughan, T. L.; Schumacher, J.; Buas, M. F.
Article Title: Biologically targeted discovery-replication scan identifies G×G interaction in relation to risk of Barrett's esophagus and esophageal adenocarcinoma
Abstract: Inherited genetics represents an important contributor to risk of esophageal adenocarcinoma (EAC), and its precursor Barrett's esophagus (BE). Genome-wide association studies have identified ∼30 susceptibility variants for BE/EAC, yet genetic interactions remain unexamined. To address challenges in large-scale G×G scans, we combined knowledge-guided filtering and machine learning approaches, focusing on genes with (1) known/plausible links to BE/EAC pathogenesis (n = 493) or (2) prior evidence of biological interactions (n = 4,196). Approximately 75 × 106 SNP×SNP interactions were screened via hierarchical group lasso (glinternet) using BEACON GWAS data. The top ∼2,000 interactions retained in each scan were prioritized using p values from single logistic models. Identical scans were repeated among males only (78%), with two independent GWAS datasets used for replication. In overall and male-specific primary replications, 11 of 187 and 20 of 191 interactions satisfied p < 0.05, respectively. The strongest evidence for secondary replication was for rs17744726×rs3217992 among males, with consistent directionality across all cohorts (Pmeta = 2.19 × 10−8); rs3217992 “T” was associated with reduced risk only in individuals homozygous for rs17744726 “G.” Rs3217992 maps to the CDKN2B 3′ UTR and reportedly disrupts microRNA-mediated repression. Rs17744726 maps to an intronic enhancer region in BLK. Through in silico prioritization and experimental validation, we identified a nearby proxy variant (rs4841556) as a functional modulator of enhancer activity. Enhancer-gene mapping and eQTLs implicated BLK and FAM167A as targets. The first systematic G×G investigation in BE/EAC, this study uncovers differential risk associations for CDKN2B variation by BLK genotype, suggesting novel biological dependency between two risk loci encoding key mediators of tumor suppression and inflammation. © 2025 The Authors
Keywords: controlled study; unclassified drug; human cell; major clinical study; single nucleotide polymorphism; microrna; mitogen activated protein kinase kinase 2; protein; genome-wide association study; gene mapping; gene interaction; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; plasmid; methylated dna protein cysteine methyltransferase; esophageal adenocarcinoma; protein kinase; protein kinase c alpha; dna isolation; transcription factor gata 4; genotyping; protein kinase c epsilon; cyclin dependent kinase inhibitor 2b; barrett esophagus; phosphodiesterase; nuclear factor; barrett's esophagus; machine learning; gene-gene interaction; human; male; female; article; luciferase assay; phosphodiesterase 2a; colecalciferol 24 hydroxylase; axis inhibition protein 1; knowledge-guided filtering; large scale computing; post-gwas; b lymphocyte kinase; cytochrome p450 4a11; disks large homolog 2; terf1 interacting nuclear factor; thioredoxin related transmembrane protein 2; g g interaction; oe19 cell line; oe33 cell line
Journal Title: Human Genetics and Genomics Advances
Volume: 6
Issue: 2
ISSN: 2666-2477
Publisher: Cell Press  
Date Published: 2025-04-10
Start Page: 100399
Language: English
DOI: 10.1016/j.xhgg.2025.100399
PUBMED: 39755942
PROVIDER: scopus
PMCID: PMC11815673
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Matthew F. Buas -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth Offit
    788 Offit
  2. Hans Gerdes
    176 Gerdes
  3. Pari Mayank Shah
    47 Shah
  4. Daniela   Molena
    272 Molena
  5. Xiang Shu
    21 Shu
  6. Shiv Prakash Verma
    2 Verma
  7. Matthew Frank Buas
    2 Buas
  8. Xu Zhang
    1 Zhang
  9. Kathryn Graz
    1 Graz
  10. Elnaz Naderi
    1 Naderi